HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T J Herzog Selected Research

DNA (Deoxyribonucleic Acid)

12/2001Genotypic and phenotypic progression in endometrial tumorigenesis: determining when defects in DNA mismatch repair and KRAS2 occur.
7/2001Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.
10/2000Clinical significance of microsatellite instability in endometrial carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T J Herzog Research Topics

Disease

11Neoplasms (Cancer)
11/2021 - 04/2000
6Endometrial Neoplasms (Endometrial Cancer)
07/2002 - 04/2000
3Ovarian Neoplasms (Ovarian Cancer)
11/2019 - 05/2007
3Ovarian Epithelial Carcinoma
01/2019 - 09/2014
2Carcinoma (Carcinomatosis)
11/2002 - 09/2001
1Microsatellite Instability
11/2021
1Disease Progression
11/2019
1Ascites
11/2001
1Hydrothorax
11/2001
1Adenocarcinoma
10/2001
1Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2000
1Fistula
11/2000
1Residual Neoplasm
11/2000
1Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
09/2000
1Hydatidiform Mole (Molar Pregnancy)
09/2000
1Choriocarcinoma
09/2000
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2000
1Colonic Neoplasms (Colon Cancer)
04/2000

Drug/Important Bio-Agent (IBA)

3DNA (Deoxyribonucleic Acid)IBA
12/2001 - 10/2000
2pazopanibFDA Link
11/2019 - 01/2018
2PlatinumIBA
01/2019 - 05/2007
2Cisplatin (Platino)FDA LinkGeneric
05/2007 - 09/2001
1Biomarkers (Surrogate Marker)IBA
11/2021
1Lapatinib (GW572016)FDA Link
09/2008
1PKI 166IBA
09/2008
1AntibodiesIBA
09/2008
1Epidermal Growth Factor (EGF)IBA
09/2008
1Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2008
1Trastuzumab (Herceptin)FDA Link
09/2008
1Cetuximab (Erbitux)FDA Link
09/2008
1matuzumabIBA
09/2008
1EKB 569IBA
09/2008
1pertuzumabIBA
09/2008
1Canertinib (CI 1033)IBA
09/2008
1vandetanib (ZD6474)IBA
09/2008
1Gefitinib (Iressa)FDA Link
09/2008
1ErbB Receptors (EGF Receptor)IBA
09/2008
1taxaneIBA
05/2007
1rubitecanIBA
11/2002
1GemcitabineFDA Link
11/2002
1Codon (Codons)IBA
12/2001
1Formaldehyde (Formol)FDA Link
07/2001
1ParaffinIBA
07/2001
1polyadenineIBA
10/2000
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
09/2000
1Topotecan (Hycamtin)FDA LinkGeneric
06/2000
1Proteins (Proteins, Gene)FDA Link
04/2000

Therapy/Procedure

8Drug Therapy (Chemotherapy)
11/2019 - 09/2000
6Therapeutics
11/2021 - 06/2000
4Hysterectomy
11/2001 - 11/2000
2Lasers (Laser)
07/2002 - 12/2001
2Lymph Node Excision (Lymph Node Dissection)
09/2001 - 11/2000
1Catheters
12/2001
1Salpingo-oophorectomy
11/2001
1Laparotomy
11/2001
1Conservative Treatment
10/2001
1Dilatation and Curettage
10/2001
1Brachytherapy
09/2001
1Chemoprevention
04/2000